First drug for chronic migraine prevention just approved by EU; it got a greenlight from the FDA in May. It’s kind of amazing that this is the first drug specifically for migraine prevention (“we can put a man on the moon…”) but better late than never? Some good quality analysis here:
[Go to the link featured in this post]
Aimovig’s performance relative to a placebo treatment is not that great; it’s not even twice as effective as placebo… But in the clinic, outside of the rarefied circles of clinical trials, clinicians are excited.
First drug for chronic migraine prevention
Orginally Published At: Pain Science